Premium Nahrungsergänzungsmittel | artgerecht

IBS Pathogenesis – Causes and Mechanisms

The pathogenesis of irritable bowel syndrome (IBS) involves complex interactions between the gut-brain axis, gut motility, the microbiome, and intestinal barrier function.

Regular tips about health Regular tips about health

Things worth knowing about "Irritable Bowel Syndrome Pathogenesis"

The pathogenesis of irritable bowel syndrome (IBS) involves complex interactions between the gut-brain axis, gut motility, the microbiome, and intestinal barrier function.

What Is the Pathogenesis of Irritable Bowel Syndrome?

The pathogenesis of irritable bowel syndrome (IBS) refers to the biological, psychological, and environmental mechanisms that lead to the development of this common functional gastrointestinal disorder. IBS is characterized by recurring abdominal pain, bloating, and altered bowel habits without identifiable structural or biochemical abnormalities. Its pathogenesis is multifactorial and remains an area of active research.

Multifactorial Causes

IBS does not arise from a single cause but rather from the interplay of several contributing factors.

Gut-Brain Axis Dysregulation

The gut-brain axis describes the bidirectional communication between the central nervous system and the enteric nervous system of the gut. In IBS patients, this communication is disrupted, leading to altered pain processing and a condition known as visceral hypersensitivity. This means the gut overreacts to normal stimuli such as gas or mild distension, producing exaggerated pain signals.

Altered Gut Motility

Many patients with IBS show changes in gut motility – the coordinated muscular contractions that move content through the intestine. Depending on the subtype, this manifests as accelerated transit (diarrhea-predominant IBS) or delayed transit (constipation-predominant IBS).

Gut Microbiome Alterations

The gut microbiome – the community of trillions of microorganisms living in the intestines – plays a key role in IBS pathogenesis. Research has demonstrated dysbiosis (an imbalance in microbial composition) in IBS patients, which can influence intestinal inflammation, barrier integrity, and nerve sensitivity.

Increased Intestinal Permeability

A compromised intestinal barrier – sometimes referred to as leaky gut – allows bacterial products to penetrate the intestinal wall, triggering local inflammatory responses that increase nerve excitability and contribute to symptom generation.

Low-Grade Mucosal Inflammation

Although IBS is traditionally classified as a non-inflammatory condition, a subset of patients shows evidence of low-grade mucosal inflammation, including activated mast cells and elevated cytokine levels within the intestinal lining.

Post-Infectious IBS

A significant proportion of IBS cases develop following an acute episode of gastroenteritis. This post-infectious IBS is attributed to persistent inflammatory changes, microbiome disruption, and psychological stress responses following the infection.

Psychosocial Factors

Stress, anxiety, depression, and adverse life events are strongly associated with IBS and can exacerbate symptoms. These factors act on gut function through the gut-brain axis, influencing motility, sensitivity, and secretion.

Symptoms

The symptoms of IBS arise from the combined effects of the above mechanisms and include:

Recurrent abdominal pain or cramping
Bloating and a feeling of abdominal distension
Diarrhea, constipation, or alternating between both
Changes in stool consistency or frequency
Sensation of incomplete bowel emptying

Diagnosis

IBS is diagnosed according to the Rome IV criteria, which require recurrent abdominal pain on at least one day per week over the past three months, associated with changes in stool frequency or consistency. Organic conditions such as inflammatory bowel disease (IBD), celiac disease, and colorectal cancer must be excluded.

Treatment

Treatment is tailored to the individual subtype and predominant symptoms and may include:

Dietary modifications: e.g., a low-FODMAP diet to reduce fermentable carbohydrates
Probiotics: to support a healthier gut microbiome
Medications: antispasmodics, laxatives, antidiarrheals, or low-dose antidepressants depending on symptoms
Psychotherapy: cognitive behavioral therapy or gut-directed hypnotherapy
Stress management: relaxation techniques such as mindfulness or yoga

References

Lacy B. E. et al. - Bowel Disorders. Gastroenterology, 2016; 150(6):1393-1407. (Rome IV Criteria)
Cryan J. F. et al. - The Microbiota-Gut-Brain Axis. Physiological Reviews, 2019; 99(4):1877-2013.
Spiller R., Garsed K. - Postinfectious Irritable Bowel Syndrome. Gastroenterology, 2009; 136(6):1979-1988.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category